A 67-year-old man presented with a several-year history of progressive gait ataxia, dysarthria, and a 2-Hz palatal tremor (video on the Neurology ® Web site at Neurology. org). He did not have corticospinal tract signs. Cranial MRI revealed hypertrophic olivary degeneration on T2-weighted images (figure). Genetic testing revealed a transition C . T, nucleotide position 235, codon 79, resulting in an arginine . cysteine change, which is a known pathogenic DNA sequence variant within the glial fibrillary acidic protein gene, confirming adult-onset Alexander disease. Symptomatic palatal tremor (SPT) results from a lesion within the dentato-rubral-olivary tracts. SPT is produced by contraction of the levator veli palatini and is usually accompanied by other neurologic signs. Essential palatal tremor, an idiopathic tremor of the tensor veli palatini, has a similar appearance to SPT, but is accompanied by a clicking sound within the ear and without additional neurologic deficits.
Teaching Video NeuroImages: Palatal tremor in adult-onset Alexander disease
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